Cabaletta Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4,010 |
Gross Profit | -426 | -393 | 3,674 | |
EBITDA | -32,622 | -29,853 | -27,638 | -22,810 |
EBIT | -33,046 | -30,279 | -28,031 | -23,146 |
Net Income | -30,629 | -27,602 | -25,047 | -20,886 |
Net Change In Cash | 0 | 0 | 0 | 4,010 |
Free Cash Flow | -20,576 | -21,559 | -24,800 | -16,633 |
Cash | 170,608 | 178,613 | 175,293 | 193,238 |
Basic Shares | 49,470 | 49,445 | 49,302 | 44,435 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $ |
Gross Profit | -1,426 | -3,684 | -733 | |
EBITDA | -73,234 | -52,961 | -45,580 | -33,479 |
EBIT | -74,660 | -54,139 | -46,313 | -33,833 |
Net Income | -67,675 | -51,811 | -45,532 | -32,491 |
Net Change In Cash | 0 | 0 | 0 | |
Cost of Revenue | -40,615 | -34,775 | ||
Free Cash Flow | -54,236 | -48,833 | -35,275 | -27,405 |
Cash | 193,238 | 81,607 | 122,222 | 101,429 |
Basic Shares | 40,945 | 29,342 | 25,737 | 23,145 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.62 |
2024-06-30 | -$0.56 |
2024-03-31 | -$0.51 |
2023-12-31 | -$0.46 |
